Effects of Inhaled Mometasone Furoate on Growth Velocity and Adrenal Function: A Placebo-Controlled Trial in Children 4–9 Years Old with Mild Persistent Asthma

References

• Akinbami L. The state of childhood asthma, United States, 1980–2005. Advance data from Vital and Health Statistics; no 381. Hyattsville, MD: National Center for Health Statistics, 2006.
   Google Scholar
• 2009 Chartbook on Cardiovascular, Lung, and Blood Diseases. National Heart, Lung, and Blood Institute. Available at: http://www.nhlbi.nih.gov/resources/docs/cht-book.htm. Accessed June 10, 2011.
   Google Scholar
• From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2010. Available at: http://www.ginasthma.org/guidelines-gina-report-global-strategy-for-asthma.html. Accessed June 10, 2011.
   Google Scholar
• National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm. Accessed June 10, 2011.
   Google Scholar
• Ricciardolo FL. The treatment of asthma in children: inhaled corticosteroids. Pulm Pharmacol Ther 2007; 20:473–482.
   PubMed Web of Science ®Google Scholar
• Kannisto S, Korppi M, Remes K, Voutilainen R. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab 2000; 85:652–657.
   PubMed Web of Science ®Google Scholar
• Skoner DP, Szefler SJ, Welch M, Walton-Bowen K, Cruz-Rivera M, Smith JA. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. J Allergy Clin Immunol 2000; 105:259–268.
   PubMed Web of Science ®Google Scholar
• Becker AB, Kuznetsova O, Vermeulen J, Soto-Quiros ME, Young B, Reiss TF, Dass SB, Knorr BA. Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study. Ann Allergy Asthma Immunol 2006; 96:800–807.
   PubMed Web of Science ®Google Scholar
• Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, Bacharier LB, Lemanske RF Jr., Strunk RC, Allen DB, Bloomberg GR, Heldt G, Krawiec M, Larsen G, Liu AH, Chinchilli VM, Sorkness CA, Taussig LM, Martinez FD. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354:1985–1997.
   Google Scholar
• Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343:1054–1063.
   PubMed Web of Science ®Google Scholar
• Leone FT, Fish JE, Szefler SJ, West SL. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest 2003; 124:2329–2340.
   PubMed Web of Science ®Google Scholar
• Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000; 343:1064–1069.
   PubMed Web of Science ®Google Scholar
• Strunk RC, Sternberg AL, Szefler SJ, Zeiger RS, Bender B, Tonascia J. Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. J Pediatr 2009; 154:682–687.
   PubMed Web of Science ®Google Scholar
• Bensch GW, Prenner B, Berkowitz R, Galant S, Ramsdell J, Lutsky B. Once-daily evening administration of mometasone furoate in asthma treatment initiation. Ann Allergy Asthma Immunol 2006; 96:533–540.
   PubMed Web of Science ®Google Scholar
• D’Urzo A, Karpel JP, Busse WW, Boulet LP, Monahan ME, Lutsky B, Staudinger H. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids. Curr Med Res Opin 2005; 21:1281–1289.
   PubMed Web of Science ®Google Scholar
• Berger WE, Milgrom H, Chervinsky P, Noonan M, Weinstein SF, Lutsky BN, Staudinger H. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma. Ann Allergy Asthma Immunol 2006; 97:672–680.
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Baena-Cagnani CE, Chervinsky P, Stewart GE II, Bronsky EA, Lutsky BN. Once-daily mometasone furoate administered by dry powder inhaler for the treatment of children with persistent asthma. Pediatr Asthma Allergy Immunol 2007; 20:67–81.
   Google Scholar
• Asmanex® Twisthaler® (mometasone furoate). Full Prescribing Information. Kenilworth, NJ, Merck & Co., Inc., 2008.
   Google Scholar
• Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. 2nd ed. Palo Alto, CA: Stanford University Press, 1959.
   Google Scholar
• Tanner J, Whitehouse R. Atlas of Children’s Growth: Normal Variation and Growth Disorders. London: Academic Press, 1982.
   Google Scholar
• Diggle PJ, Liang KY, Zeger SL. The Analysis of Longitudinal Data. Oxford: Clarendon Press, 1993.
   Google Scholar
• Nicoll C. Therapeutic Drug Monitoring and Laboratory Reference Ranges. In: McPhee S, Papadakis M, Tierney L, eds. Current Medical Diagnosis and Treatment. 47th ed. New York: McGraw Hill Medical, 2008:1494.
   Google Scholar
• Bernstein DI, Berkowitz RB, Chervinsky P, Dvorin DJ, Finn AF, Gross GN, Karetzky M, Kemp JP, Laforce C, Lumry W, Mendelson LM, Nelson H, Pearlman D, Rachelefsky G, Ratner P, Repsher L, Segal AT, Selner JC, Settipane GA, Wanderer A, Cuss FM, Nolop KB, Harrison JE. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler. Respir Med 1999; 93:603–612.
   PubMed Web of Science ®Google Scholar
• Bousquet J, D’Urzo A, Hebert J, Barraza CH, Boulet LP, Suarez-Chacon R, Harnest U, Lundback B, Martinez Morales G, Nieminen MM, Nolop KB, Visser S, Lutsky BN. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler. Eur Respir J 2000; 16:808–816.
   PubMed Web of Science ®Google Scholar
• O’Connor B, Bonnaud G, Haahtela T, Luna JM, Querfurt H, Wegener T, Lutsky BN. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. Ann Allergy Asthma Immunol 2001; 86:397–404.
   PubMed Web of Science ®Google Scholar
• Nayak AS, Banov C, Corren J, Feinstein BK, Floreani A, Friedman BF, Goldsobel A, Gottschlich GM, Hannaway PJ, Lampl KL, Lapidus RJ, Lawrence M, Lumry W, Munk Z, Pearlman D, Scardella AT, Schenkel EJ, Segal AT, Segall N, Silverman B, Shneyer L, Nolop KB, Harrison JE. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma. Ann Allergy Asthma Immunol 2000; 84:417–424.
   PubMed Web of Science ®Google Scholar
• Kemp JP, Berkowitz RB, Miller SD, Murray JJ, Nolop K, Harrison JE. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma. J Allergy Clin Immunol 2000; 106:485–492.
   PubMed Web of Science ®Google Scholar
• Noonan M, Karpel JP, Bensch GW, Ramsdell JW, Webb DR, Nolop KB, Lutsky BN. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler. Ann Allergy Asthma Immunol 2001; 86:36–43.
   PubMed Web of Science ®Google Scholar
• Karpel JP, Busse WW, Noonan MJ, Monahan ME, Lutsky B, Staudinger H. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma. Ann Pharmacother 2005; 39:1977–1983.
   PubMed Web of Science ®Google Scholar
• Fish JE, Karpel JP, Craig TJ, Bensch GW, Noonan M, Webb DR, Silverman B, Schenkel EJ, Rooklin AR, Ramsdell JW, Nathan R, Leflein JG, Grossman J, Graft DF, Gower RG, Garay SM, Frigas E, Degraff AC, Bronsky EA, Bernstein DI, Berger W, Shneyer L, Nolop KB, Harrison JE. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. J Allergy Clin Immunol 2000; 106:852–860.
   PubMed Web of Science ®Google Scholar
• Wardlaw A, Larivee P, Eller J, Cockcroft DW, Ghaly L, Harris AG. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate. Ann Allergy Asthma Immunol 2004; 93:49–55.
   PubMed Web of Science ®Google Scholar
• Allen DB. Inhaled corticosteroid therapy for asthma in preschool children: growth issues. Pediatrics 2002; 109:373–380.
   PubMed Web of Science ®Google Scholar
• Lemanske R, Lockey R, Murphy K. Effects of one year of treatment with mometasone furoate metered dose inhaler (MF-MDI) on growth in children with asthma [abstract]. Eur Respir J 2004; 24:378s.
   PubMed Web of Science ®Google Scholar
• Daley-Yates PT, Richards DH. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model. Clin Ther 2004; 26:1905–1919.
   PubMed Web of Science ®Google Scholar
• Thorsson L, Edsbacker S, Conradson TB. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI. Eur Respir J 1994; 7:1839–1844.
   PubMed Web of Science ®Google Scholar
• Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 2000; 343:1054–1063.
   PubMed Web of Science ®Google Scholar
• Daley-Yates PT, Price AC, Sisson JR, Pereira A, Dallow N. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol 2001; 51:400–409.
   PubMed Web of Science ®Google Scholar
• Martinez FD, Chinchilli VM, Morgan WJ, Boehmer SJ, Lemanske RF Jr., Mauger DT, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bade E, Covar RA, Friedman NJ, Guilbert TW, Heidarian-Raissy H, Kelly HW, Malka-Rais J, Mellon MH, Sorkness CA, Taussig L. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet 2011; 377:650–657.
   PubMed Web of Science ®Google Scholar
• Thorsson L, Dahlstrom K, Edsbacker S, Kallen A, Paulson J, Wiren JE. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol 1997; 43:155–161.
   PubMed Web of Science ®Google Scholar
• Allen DB, Bronsky EA, LaForce CF, Nathan RA, Tinkelman DG, Vandewalker ML, Konig P. Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group. J Pediatr 1998; 132:472–477.
   Google Scholar
• Affrime MB, Cuss F, Padhi D, Wirth M, Pai S, Clement RP, Lim J, Kantesaria B, Alton K, Cayen MN. Bioavailability and metabolism of mometasone furoate following administration by metered-dose and dry-powder inhalers in healthy human volunteers. J Clin Pharmacol 2000; 40:1227–1236.
   PubMed Web of Science ®Google Scholar
• Affrime MB, Kosoglou T, Thonoor CM, Flannery BE, Herron JM. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses. Chest 2000; 118:1538–1546.
   PubMed Web of Science ®Google Scholar
• Fardon TC, Lee DK, Haggart K, McFarlane LC, Lipworth BJ. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate. Am J Respir Crit Care Med 2004; 170:960–966.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Orally Inhaled and Intranasal Corticosteroids: Evaluation of the Effects on Growth in Children. Guidance for Industry; 2007. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071968.pdf. Accessed June 10, 2011.
   Google Scholar
• Yang TT, Li S, Wyka B, Kenyon D. Drug delivery performance of the mometasone furoate dry powder inhaler. J Aerosol Med 2001; 14:487–494.
   PubMedGoogle Scholar
• Skoner D, Angellini B, Gentile D, Kenyon D. Pediatric airflow profiles with the new mometasone furoate dry powder inhaler (MF-DPI) [Abstract]. J Allergy Clin Immunol 2000; 106:S16.
   Google Scholar
• Skoner DP, Maspero J, Banerji D. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics 2008; 121:e1–e14.
   PubMed Web of Science ®Google Scholar
• Price J, Hindmarsh P, Hughes S, Effthimiou J. Evaluating the effects of asthma therapy on childhood growth: principles of study design. Eur Respir J 2002; 19:1167–1178.
   PubMed Web of Science ®Google Scholar